# NVIDIA

Source: https://onco.cc/companies/nvidia/  
OnCo record `nvidia` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Supplies the GPUs and the BioNeMo framework most biological foundation models are trained on, and co-developed Evo 2 with Arc.

## Summary

NVIDIA, based in Santa Clara and listed as NVDA, supplies the GPUs and the BioNeMo framework on which most biological foundation models are trained, and it co-developed Evo 2 with the Arc Institute. BioNeMo packages training and inference recipes for protein, DNA and single-cell models, and the company partners with Arc, Recursion and many pharmaceutical groups. OnCo links it to Evo 2, BioNeMo, AI compute and model platforms for oncology and federated learning. Whether dependence on one hardware and software supplier shapes which biological models get built is the fair question about its position. Evo 2 and BioNeMo have their own technology pages.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: ai; infrastructure
- HQ: Santa Clara, CA
- Type: ai-software
- Website: https://www.nvidia.com/en-us/clara/biopharma/
- Ticker: NVDA

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Nvidia
- Official website: https://www.nvidia.com/en-us/clara/biopharma/

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/)
- technologies: [AI compute and model platforms for oncology](https://onco.cc/technologies/ai-compute-platforms/), [Evo 2 (Arc Institute, NVIDIA)](https://onco.cc/technologies/evo2/), [Federated learning and privacy-preserving AI](https://onco.cc/technologies/federated-learning-medical-ai/), [NVIDIA BioNeMo](https://onco.cc/technologies/bionemo/)
- roadmaps: [AI in oncology roadmap: pattern readers → foundation models → agents in the workflow](https://onco.cc/roadmaps/ai-oncology-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/nvidia.json